Genmab — Marts 2026
-
Hvis ikke I allerede har gjort det, så indgiv jeres stemmer til generalforsamlingen online på forhånd via Genmabs investorportal, hvis ikke I møder op eller har en repræsentant for at kunne stemme på selve generalforsamlingen i morgen kl. 14. Alle stemmer tæller, hvis I er enige/uenige med beslutningerne.
-
1761 / 6 - Tissue Factor expression is associated with B7-H4-mediated immune evasion in ovarian clear cell carcinoma and with response to tisotumab vedotin in preclinical models https://www.abstractsonline.com/pp8/#!/21436/presentation/4318
-
The Annual General Meeting 2026 will take place on Thursday, March 19, at 2:00 PM CET https://ir.genmab.com/events/event-details/annual-general-meeting-2026
-
Der står 1,9 mio DKK... ikke stk.
-
Aaahh.. thx for clarifiation, EL!
-
looks like we may get some data on Rina-s early april -Rinatabart sesutecan (Rina-S) plus bevacizumab (BEV) for patients (pts) with recurrent ovarian cancer (OC): First disclosure from cohort D2 of the phase 1/2 RAINFOL-01 study
Monday, April 13, 2026 via https://sgo2026annualmeeting.eventscribe.net/agenda.asp?BCFO=M|P&pfp=Browse by Day&fa=&fb=&fc=&fd=&all=1 -
Genmabs anbefaling sættes op til "køb" hos Baptista https://proinvestor.com/investornyt/1424224/genmabs-anbefaling-saettes-op-til-kob-hos-baptista
-
Så er vi nede i 1500-regi
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind